{"id":4422,"date":"2019-03-26T06:10:52","date_gmt":"2019-03-26T06:10:52","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4422"},"modified":"2019-03-26T06:10:52","modified_gmt":"2019-03-26T06:10:52","slug":"registro-internacional-de-trastornos-histiociticos-raros-irhdr","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/es\/study_trials\/international-rare-histiocytic-disorders-registry-irhdr\/","title":{"rendered":"Registro Internacional de Enfermedades Histioc\u00edticas Raras (IRHDR)"},"content":{"rendered":"<p><strong>Objetivo del estudio:&nbsp;<\/strong> La creaci\u00f3n de un Registro Internacional de Trastornos Histioc\u00edticos Raros (IRHDR) facilitar\u00e1 un diagn\u00f3stico uniforme de los trastornos histioc\u00edticos raros (RHD), as\u00ed como la recopilaci\u00f3n y el an\u00e1lisis de los datos cl\u00ednicos, epidemiol\u00f3gicos, terap\u00e9uticos y de supervivencia de los pacientes con RHD. El registro tambi\u00e9n ofrecer\u00e1 revisiones patol\u00f3gicas realizadas por expertos y podr\u00eda dar lugar a futuras recomendaciones terap\u00e9uticas.\u00a0 Adem\u00e1s, el IRHDR puede servir de marco para futuros ensayos cl\u00ednicos, creando as\u00ed excelentes oportunidades de investigaci\u00f3n. Por \u00faltimo, en el futuro podr\u00eda lograrse, a trav\u00e9s del IRHDR, una vinculaci\u00f3n anonimizada entre los datos cl\u00ednicos y los estudios de biolog\u00eda complementaria.  Esto podr\u00eda contribuir a\u00fan m\u00e1s a comprender la etiolog\u00eda de estas enfermedades raras, as\u00ed como a identificar posibles dianas terap\u00e9uticas.<\/p>\n<p><strong>Investigador principal:<\/strong>&nbsp; Dr. Oussama Abla, 416-813-7879, oussama.abla@sickkids.ca \u2013 O BIEN \u2013 Prerna Chopra, 416-813-7654, ext. 202043, prerna.chopra@sickkids.ca<\/p>\n<p><strong>Participaci\u00f3n solicitada del paciente:<\/strong>&nbsp; Cualquier paciente al que se le haya diagnosticado ECD (vivo o fallecido) puede ser incluido en este ensayo si se dispone de una muestra patol\u00f3gica adecuada para su revisi\u00f3n centralizada.<\/p>\n<p><strong>Identificador de ClinicalTrials.gov:<\/strong> NCT02285582<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective:&nbsp; The creation of an International Rare Histiocytic Disorders Registry (IRHDR) will facilitate a uniform diagnosis of the RHD\u2019s, as well as the collection and analysis of the clinical, [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[35],"class_list":["post-4422","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-registry"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/study_trials\/4422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/media?parent=4422"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/es\/wp-json\/wp\/v2\/study_trials_cat?post=4422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}